Skip to main content
. 2016 Sep 25;6(12):2250–2266. doi: 10.7150/thno.15710

Scheme 1.

Scheme 1

The synergistic therapeutic effects of HA-siCD98/CUR-NPs against UC. (a) A schematic illustration for the fabrication of HA-siCD98/CUR-NPs. (b) Oral administration of HA-siCD98/CUR-NPs embedded in hydrogel (chitosan/alginate) confers synergistic therapeutic effects against UC by protecting mucosa and alleviating inflammation.